美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

GRI BIO INC

2.30

+0.01820.80%

成交量：2.43萬

成交額：5.61萬

市值：332.09萬

市盈率：-0.02

高：2.35

開：2.31

低：2.27

收：2.28

52周最高：311.36

52周最低：2.10

股本：144.50萬

流通股本：31.87萬

量比：0.62

換手率：7.62%

股息：- -

股息率：- -

每股收益(TTM):-121.8000

每股收益(LYR):-1,545.7611

淨資產收益率：-238.17%

總資產收益率：-103.93%

市淨率：0.55

市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告

Gri Bio, Inc.盤中異動早盤股價大跌5.49%

Gri Bio, Inc.盤中異動急速下挫7.53%報2.21美元

GRI BIO INC重申2025財年全年業績，強化資產負債表，並概述近期關鍵進展

GRI BIO INC公布引人注目的2a期新基因表達數據顯示特發性肺纖維化關鍵驅動因子及肺修復指標改善

GRI Bio Inc：GRI-0621持續展現卓越特性，兼具良好安全性與耐受性

GRI Bio公布IPF二期a期研究新增積極數據，強化GRI-0621臨床概念驗證

Gri Bio, Inc.盤中異動早盤股價大跌5.40%報0.261美元

中國保險行業協會編撰出版《<保險機構環境、社會和治理信息披露指南>釋義及案例》

GRI Bio Inc：第二階段2a研究達到了次要終點，並顯示膠原蛋白代謝標誌物的改善

BUZZ-實驗性肺部藥物在中期試驗中表現良好，GRI 生物公司業績大增

GRI Bio公布特發性肺纖維化（「IPF」）II期2a研究的積極頂線數據

GRI Bio Inc - 試驗達到主要終點及某些次要終點；GRI-0621 耐受性良好 - SEC 備案

GRI Bio Inc - 接收特發性肺纖維化2a期臨床試驗的初步數據 - SEC備案

我們找到了離「商業向善」最近的55家公司丨2025「可持續品牌典範」排行榜公示

我國綠色貿易領域首個專項政策文件出爐綠色貿易邁向系統推進新階段

呂建中：企業應從三大方向把握綠色貿易新政機遇

我國綠色貿易領域首個專項政策文件出爐綠色貿易邁向系統推進新階段

Gri Bio, Inc.盤中異動下午盤快速拉升6.32%

全球報告倡議組織（GRI）前董事呂建中：ESG標準建設需把握「三組平衡」，推動上海可持續發展與國際接軌

Gri Bio, Inc.盤中異動早盤大幅拉升5.24%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GRI/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRI\",,,,,undefined,":{"symbol":"GRI","market":"US","secType":"STK","nameCN":"GRI BIO INC","latestPrice":2.2982,"timestamp":1772654357258,"preClose":2.28,"halted":0,"volume":24276,"delay":0,"changeRate":0.007982456140350973,"floatShares":318671,"shares":1445000,"eps":-121.8,"marketStatus":"交易中","change":0.0182,"latestTime":"03-04 15:02:10 EST","open":2.31,"high":2.35,"low":2.2661,"amount":56110.15053,"amplitude":0.036798,"askPrice":2.33,"askSize":155,"bidPrice":2.28,"bidSize":599,"shortable":0,"etf":0,"ttmEps":-121.8,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1772658000000},"marketStatusCode":2,"symbolChange":{"newSymbol":"RDOG","executeDate":"2020-01-02"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.28,"sharesOutstanding":1100000,"nav":47.93,"aum":52503274.57,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":2.3,"preClose":2.28,"latestTime":"09:16 EST","volume":345,"amount":800.4500250000001,"timestamp":1772633798613,"change":0.02,"changeRate":0.008772,"amplitude":0.013158},"postHourTrading":{"tag":"盘后","latestPrice":2.29,"preClose":2.28,"latestTime":"18:56 EST","volume":196,"amount":456.05,"timestamp":1772582168008,"change":0.01,"changeRate":0.004386,"amplitude":0.004386},"volumeRatio":0.619895},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRI\",,,,,undefined,":{"symbol":"GRI","floatShares":318671,"roa":"-103.93%","roe":"-238.17%","lyrEps":-1545.761084,"volumeRatio":0.619895,"shares":1445000,"dividePrice":0,"high":2.35,"amplitude":0.036798,"preClose":2.28,"low":2.2661,"week52Low":2.1,"pbRate":"0.55","week52High":311.36,"institutionHeld":0,"latestPrice":2.2982,"committee":0.588859,"eps":-121.8,"divideRate":0,"volume":24276,"delay":0,"ttmEps":-121.8,"open":2.31,"prevYearClose":6.9104,"prevWeekClose":2.55,"prevMonthClose":2.55,"prevQuarterClose":6.9104,"fiveDayClose":2.49,"twentyDayClose":2.6,"sixtyDayClose":59.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRI\",params:#limit:5,,,undefined,":[{"date":"2026-02-04","symbol":"GRI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770195600000,"name":null,"time":"盤前","dateTimestamp":1770181200000,"actualEps":null},{"market":"US","date":"2026-01-26","symbol":"GRI","defaultRemindTime":1769437800000,"type":"split","dateTimestamp":1769403600000,"forFactor":28,"toFactor":1,"ratio":28},{"market":"US","date":"2025-11-14","symbol":"GRI","fiscalQuarterEnding":"2025/09","expectedEps":-1.11,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-1.28},{"market":"US","date":"2025-08-14","symbol":"GRI","fiscalQuarterEnding":"2025/06","expectedEps":-1.31,"name":null,"time":"盤前","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2025-05-15","symbol":"GRI","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-5.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRI\",market:\"US\",,,undefined,":[{"executeDate":"2017-06-21","recordDate":null,"paymentDate":null,"value":0.35098,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":null,"paymentDate":null,"value":0.3314,"currency":"USD"},{"executeDate":"2018-03-22","recordDate":null,"paymentDate":null,"value":0.21998,"currency":"USD"},{"executeDate":"2018-06-21","recordDate":null,"paymentDate":null,"value":0.43792,"currency":"USD"},{"executeDate":"2018-09-20","recordDate":null,"paymentDate":null,"value":0.22115,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1733806800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRI","date":"2026-03-03","current":-0.019007,"percent":0.525424,"low":-67.389471,"twenty":-0.59462,"median":-0.314242,"eighty":-0.104916,"high":-0.026053,"avg":-0.820847,"sd":2.852964,"marketCap":3670373},"quantilePoints":[{"date":"2023-04-28","current":-6.452842,"twenty":-43.014819,"median":-6.452842,"eighty":-5.86271,"marketCap":20758792},{"date":"2023-05-05","current":-6.462034,"twenty":-6.958407,"median":-6.590723,"eighty":-6.414235,"marketCap":20788363},{"date":"2023-05-12","current":-6.241424,"twenty":-6.746989,"median":-6.452842,"eighty":-6.208332,"marketCap":20078661},{"date":"2023-05-19","current":-5.533634,"twenty":-6.616461,"median":-6.31496,"eighty":-5.658793,"marketCap":17801699},{"date":"2023-05-26","current":-5.561302,"twenty":-6.458357,"median":-6.186271,"eighty":-5.598088,"marketCap":17890708},{"date":"2023-06-02","current":-5.262646,"twenty":-6.452842,"median":-5.82778,"eighty":-5.482158,"marketCap":16929933},{"date":"2023-06-09","current":-5.525778,"twenty":-6.449165,"median":-5.749648,"eighty":-5.42597,"marketCap":17776429},{"date":"2023-06-16","current":-5.552999,"twenty":-6.425266,"median":-5.726667,"eighty":-5.42597,"marketCap":17863998},{"date":"2023-06-23","current":-5.27172,"twenty":-6.388497,"median":-5.639618,"eighty":-5.389675,"marketCap":16959122},{"date":"2023-06-30","current":-3.937911,"twenty":-6.292899,"median":-5.570402,"eighty":-5.286238,"marketCap":12668260},{"date":"2023-07-07","current":-3.937911,"twenty":-6.252454,"median":-5.552999,"eighty":-5.259017,"marketCap":12668260},{"date":"2023-07-14","current":-2.385349,"twenty":-6.208332,"median":-5.497533,"eighty":-4.422437,"marketCap":12084177},{"date":"2023-07-21","current":-2.080028,"twenty":-6.169725,"median":-5.444117,"eighty":-3.992352,"marketCap":10537423},{"date":"2023-07-28","current":-2.074266,"twenty":-6.062039,"median":-5.398749,"eighty":-2.492577,"marketCap":10508234},{"date":"2023-08-04","current":-2.016648,"twenty":-5.895709,"median":-5.29894,"eighty":-2.286879,"marketCap":10216339},{"date":"2023-08-11","current":-1.670937,"twenty":-5.80594,"median":-5.269392,"eighty":-2.115752,"marketCap":8464966},{"date":"2023-08-18","current":-0.705381,"twenty":-5.784454,"median":-5.253573,"eighty":-2.071731,"marketCap":8123173},{"date":"2023-08-25","current":-0.379941,"twenty":-5.775512,"median":-4.672867,"eighty":-2.016648,"marketCap":4375403},{"date":"2023-09-01","current":-0.326031,"twenty":-5.745051,"median":-4.137529,"eighty":-1.921001,"marketCap":3754569},{"date":"2023-09-08","current":-0.3029,"twenty":-5.7189,"median":-4.028646,"eighty":-1.605021,"marketCap":3488202},{"date":"2023-09-15","current":-0.344001,"twenty":-5.680197,"median":-3.282658,"eighty":-0.71008,"marketCap":3961514},{"date":"2023-09-22","current":-0.388926,"twenty":-5.612229,"median":-2.48912,"eighty":-0.572479,"marketCap":4478876},{"date":"2023-09-29","current":-0.427434,"twenty":-5.570848,"median":-2.355128,"eighty":-0.40895,"marketCap":4922329},{"date":"2023-10-06","current":-0.431285,"twenty":-5.566762,"median":-2.183742,"eighty":-0.40818,"marketCap":4966674},{"date":"2023-10-13","current":-0.385076,"twenty":-5.557981,"median":-2.111719,"eighty":-0.394317,"marketCap":4434531},{"date":"2023-10-20","current":-0.30806,"twenty":-5.545253,"median":-2.080028,"eighty":-0.388156,"marketCap":3547624},{"date":"2023-10-27","current":-0.29009,"twenty":-5.537507,"median":-2.074266,"eighty":-0.385076,"marketCap":3340680},{"date":"2023-11-03","current":-0.313195,"twenty":-5.527349,"median":-2.035374,"eighty":-0.378144,"marketCap":3606751},{"date":"2023-11-10","current":-0.326031,"twenty":-5.480587,"median":-2.016648,"eighty":-0.338353,"marketCap":3754569},{"date":"2023-11-17","current":-0.236451,"twenty":-5.463669,"median":-1.982077,"eighty":-0.328085,"marketCap":3145265},{"date":"2023-11-24","current":-0.183038,"twenty":-5.451376,"median":-1.754484,"eighty":-0.323726,"marketCap":2434765},{"date":"2023-12-01","current":-0.149115,"twenty":-5.430507,"median":-1.596033,"eighty":-0.313195,"marketCap":1983522},{"date":"2023-12-08","current":-0.135594,"twenty":-5.413267,"median":-1.130208,"eighty":-0.310628,"marketCap":1803674},{"date":"2023-12-15","current":-0.104697,"twenty":-5.396934,"median":-0.705381,"eighty":-0.306725,"marketCap":1392685},{"date":"2023-12-22","current":-0.090567,"twenty":-5.373343,"median":-0.587882,"eighty":-0.302916,"marketCap":1204721},{"date":"2023-12-29","current":-0.094904,"twenty":-5.349752,"median":-0.438986,"eighty":-0.2983,"marketCap":1262416},{"date":"2024-01-05","current":-0.110474,"twenty":-5.311643,"median":-0.435136,"eighty":-0.294711,"marketCap":1469527},{"date":"2024-01-12","current":-0.109217,"twenty":-5.291682,"median":-0.427434,"eighty":-0.246147,"marketCap":1452802},{"date":"2024-01-19","current":-0.097153,"twenty":-5.278979,"median":-0.423583,"eighty":-0.216462,"marketCap":1292334},{"date":"2024-01-26","current":-0.094979,"twenty":-5.268926,"median":-0.399195,"eighty":-0.171402,"marketCap":1263405},{"date":"2024-02-02","current":-0.094661,"twenty":-5.264413,"median":-0.392777,"eighty":-0.137831,"marketCap":1259185},{"date":"2024-02-09","current":-0.06068,"twenty":-5.257202,"median":-0.388926,"eighty":-0.126623,"marketCap":807170},{"date":"2024-02-16","current":-0.051457,"twenty":-5.14469,"median":-0.385076,"eighty":-0.111663,"marketCap":684480},{"date":"2024-02-23","current":-0.04102,"twenty":-4.999514,"median":-0.382508,"eighty":-0.110454,"marketCap":545646},{"date":"2024-03-01","current":-0.03886,"twenty":-4.71642,"median":-0.375448,"eighty":-0.10718,"marketCap":516911},{"date":"2024-03-08","current":-0.039161,"twenty":-4.422437,"median":-0.344001,"eighty":-0.100549,"marketCap":520915},{"date":"2024-03-15","current":-0.03767,"twenty":-4.279076,"median":-0.334836,"eighty":-0.098655,"marketCap":501091},{"date":"2024-03-22","current":-0.038156,"twenty":-4.093976,"median":-0.328598,"eighty":-0.095596,"marketCap":507548},{"date":"2024-03-28","current":-0.03767,"twenty":-4.028646,"median":-0.326031,"eighty":-0.094235,"marketCap":501091},{"date":"2024-04-05","current":-0.0264,"twenty":-4.010499,"median":-0.323464,"eighty":-0.087028,"marketCap":344177},{"date":"2024-04-12","current":-0.125045,"twenty":-3.937911,"median":-0.313195,"eighty":-0.088985,"marketCap":1630208},{"date":"2024-04-19","current":-0.126859,"twenty":-3.67581,"median":-0.313195,"eighty":-0.09094,"marketCap":1653862},{"date":"2024-04-26","current":-0.105479,"twenty":-2.6009,"median":-0.310628,"eighty":-0.09277,"marketCap":1375129},{"date":"2024-05-03","current":-0.105185,"twenty":-2.49373,"median":-0.30806,"eighty":-0.094235,"marketCap":1371293},{"date":"2024-05-10","current":-0.10033,"twenty":-2.46953,"median":-0.302926,"eighty":-0.09471,"marketCap":1308002},{"date":"2024-05-17","current":-0.103221,"twenty":-2.390004,"median":-0.302913,"eighty":-0.094919,"marketCap":1318551},{"date":"2024-05-24","current":-0.122034,"twenty":-2.373261,"median":-0.297792,"eighty":-0.095113,"marketCap":1558863},{"date":"2024-05-31","current":-0.089235,"twenty":-2.324907,"median":-0.295225,"eighty":-0.094904,"marketCap":1139886},{"date":"2024-06-07","current":-0.082262,"twenty":-2.229836,"median":-0.270731,"eighty":-0.09243,"marketCap":1050809},{"date":"2024-06-14","current":-0.067369,"twenty":-2.183742,"median":-0.243952,"eighty":-0.086638,"marketCap":860576},{"date":"2024-06-21","current":-0.06046,"twenty":-2.183742,"median":-0.236451,"eighty":-0.084684,"marketCap":772312},{"date":"2024-06-28","current":-0.04364,"twenty":-2.142256,"median":-0.183038,"eighty":-0.080138,"marketCap":557458},{"date":"2024-07-05","current":-0.035685,"twenty":-2.107685,"median":-0.169273,"eighty":-0.077002,"marketCap":455838},{"date":"2024-07-12","current":-0.039549,"twenty":-2.084638,"median":-0.148382,"eighty":-0.067451,"marketCap":505197},{"date":"2024-07-19","current":-0.133962,"twenty":-2.080028,"median":-0.136425,"eighty":-0.065043,"marketCap":1711236},{"date":"2024-07-26","current":-0.250214,"twenty":-2.076571,"median":-0.134227,"eighty":-0.066114,"marketCap":3196229},{"date":"2024-08-02","current":-0.123557,"twenty":-2.070463,"median":-0.136308,"eighty":-0.067151,"marketCap":1578317},{"date":"2024-08-09","current":-0.119179,"twenty":-2.057903,"median":-0.134149,"eighty":-0.067451,"marketCap":1522398},{"date":"2024-08-16","current":-0.173723,"twenty":-2.032205,"median":-0.134188,"eighty":-0.068945,"marketCap":1438081},{"date":"2024-08-23","current":-0.180019,"twenty":-2.0178,"median":-0.137022,"eighty":-0.072461,"marketCap":1490194},{"date":"2024-08-30","current":-0.179523,"twenty":-2.016648,"median":-0.143852,"eighty":-0.075548,"marketCap":1486095},{"date":"2024-09-06","current":-0.181256,"twenty":-2.012038,"median":-0.150555,"eighty":-0.076825,"marketCap":1500441},{"date":"2024-09-13","current":-0.17772,"twenty":-1.99821,"median":-0.158633,"eighty":-0.077735,"marketCap":1471164},{"date":"2024-09-20","current":-0.155898,"twenty":-1.983229,"median":-0.162446,"eighty":-0.078438,"marketCap":1290525},{"date":"2024-09-27","current":-0.157737,"twenty":-1.921001,"median":-0.162689,"eighty":-0.07939,"marketCap":1305749},{"date":"2024-10-04","current":-0.126614,"twenty":-1.771193,"median":-0.158185,"eighty":-0.081212,"marketCap":1048113},{"date":"2024-10-11","current":-0.142706,"twenty":-1.649964,"median":-0.155898,"eighty":-0.082328,"marketCap":1181323},{"date":"2024-10-18","current":-0.205129,"twenty":-1.609516,"median":-0.156191,"eighty":-0.082669,"marketCap":1698060},{"date":"2024-10-25","current":-0.253618,"twenty":-1.58474,"median":-0.158633,"eighty":-0.083857,"marketCap":2099446},{"date":"2024-11-01","current":-0.389038,"twenty":-1.55835,"median":-0.162689,"eighty":-0.085216,"marketCap":3220459},{"date":"2024-11-08","current":-0.309533,"twenty":-1.213002,"median":-0.16573,"eighty":-0.0855,"marketCap":2562314},{"date":"2024-11-15","current":-0.834738,"twenty":-0.956624,"median":-0.168878,"eighty":-0.086051,"marketCap":6897440},{"date":"2024-11-22","current":-0.744896,"twenty":-0.798801,"median":-0.172945,"eighty":-0.087419,"marketCap":6155078},{"date":"2024-11-29","current":-0.73895,"twenty":-0.817115,"median":-0.173652,"eighty":-0.088719,"marketCap":6105945},{"date":"2024-12-06","current":-0.85409,"twenty":-0.817115,"median":-0.175474,"eighty":-0.089501,"marketCap":7057347},{"date":"2024-12-13","current":-0.864901,"twenty":-0.90556,"median":-0.177225,"eighty":-0.09094,"marketCap":7146680},{"date":"2024-12-20","current":-0.800034,"twenty":-0.862739,"median":-0.178604,"eighty":-0.092559,"marketCap":6610679},{"date":"2024-12-27","current":-0.840252,"twenty":-0.85409,"median":-0.179258,"eighty":-0.093076,"marketCap":6943000},{"date":"2025-01-03","current":-0.980582,"twenty":-0.899629,"median":-0.179576,"eighty":-0.093918,"marketCap":8102549},{"date":"2025-01-10","current":-0.824359,"twenty":-0.897162,"median":-0.179967,"eighty":-0.094448,"marketCap":6811680},{"date":"2025-01-17","current":-0.778736,"twenty":-0.894437,"median":-0.183038,"eighty":-0.094807,"marketCap":6434692},{"date":"2025-01-24","current":-0.664677,"twenty":-0.882156,"median":-0.183767,"eighty":-0.094934,"marketCap":5492224},{"date":"2025-01-31","current":-0.683272,"twenty":-0.864036,"median":-0.186432,"eighty":-0.095246,"marketCap":5645877},{"date":"2025-02-07","current":-0.51786,"twenty":-0.859279,"median":-0.188825,"eighty":-0.095801,"marketCap":4279075},{"date":"2025-02-14","current":-0.59462,"twenty":-0.851712,"median":-0.211495,"eighty":-0.096227,"marketCap":4913342},{"date":"2025-02-21","current":-0.448668,"twenty":-0.847171,"median":-0.237801,"eighty":-0.096648,"marketCap":3707340},{"date":"2025-02-28","current":-0.503678,"twenty":-0.842674,"median":-0.243952,"eighty":-0.097277,"marketCap":4161888},{"date":"2025-03-07","current":-0.417118,"twenty":-0.839149,"median":-0.250793,"eighty":-0.097785,"marketCap":3446642},{"date":"2025-03-14","current":-0.38344,"twenty":-0.834284,"median":-0.285059,"eighty":-0.097973,"marketCap":3146894},{"date":"2025-03-21","current":-0.529391,"twenty":-0.832468,"median":-0.291725,"eighty":-0.098547,"marketCap":4344710},{"date":"2025-03-28","current":-0.279508,"twenty":-0.831517,"median":-0.292657,"eighty":-0.098601,"marketCap":2293923},{"date":"2025-04-04","current":-0.09666,"twenty":-0.827041,"median":-0.290527,"eighty":-0.098547,"marketCap":793290},{"date":"2025-04-11","current":-0.085138,"twenty":-0.823818,"median":-0.279508,"eighty":-0.096759,"marketCap":698726},{"date":"2025-04-17","current":-0.09666,"twenty":-0.821656,"median":-0.251372,"eighty":-0.09666,"marketCap":793290},{"date":"2025-04-25","current":-0.116504,"twenty":-0.814953,"median":-0.245324,"eighty":-0.09666,"marketCap":956151},{"date":"2025-05-02","current":-0.134428,"twenty":-0.809764,"median":-0.239152,"eighty":-0.09666,"marketCap":1103251},{"date":"2025-05-09","current":-0.0941,"twenty":-0.808683,"median":-0.211495,"eighty":-0.09666,"marketCap":772276},{"date":"2025-05-16","current":-0.084138,"twenty":-0.800034,"median":-0.204843,"eighty":-0.096031,"marketCap":788037},{"date":"2025-05-23","current":-0.070115,"twenty":-0.798953,"median":-0.187157,"eighty":-0.094904,"marketCap":656697},{"date":"2025-05-30","current":-0.343344,"twenty":-0.795147,"median":-0.196834,"eighty":-0.094964,"marketCap":3215762},{"date":"2025-06-06","current":-0.358381,"twenty":-0.793245,"median":-0.205801,"eighty":-0.0953,"marketCap":3356598},{"date":"2025-06-13","current":-0.350863,"twenty":-0.792574,"median":-0.237801,"eighty":-0.095594,"marketCap":3286180},{"date":"2025-06-20","current":-0.350863,"twenty":-0.79052,"median":-0.242668,"eighty":-0.095877,"marketCap":3286180},{"date":"2025-06-27","current":-0.320789,"twenty":-0.782931,"median":-0.250214,"eighty":-0.096326,"marketCap":3004508},{"date":"2025-07-03","current":-0.360887,"twenty":-0.772292,"median":-0.253618,"eighty":-0.096577,"marketCap":3380071},{"date":"2025-07-11","current":-0.395974,"twenty":-0.758129,"median":-0.287575,"eighty":-0.09666,"marketCap":3708689},{"date":"2025-07-18","current":-0.519833,"twenty":-0.748788,"median":-0.292486,"eighty":-0.09666,"marketCap":4868760},{"date":"2025-07-25","current":-0.525165,"twenty":-0.744896,"median":-0.295553,"eighty":-0.096857,"marketCap":4918696},{"date":"2025-08-01","current":-0.341224,"twenty":-0.744464,"median":-0.297792,"eighty":-0.097401,"marketCap":3195904},{"date":"2025-08-08","current":-0.333227,"twenty":-0.742821,"median":-0.300679,"eighty":-0.097796,"marketCap":3121000},{"date":"2025-08-15","current":-0.359252,"twenty":-0.741156,"median":-0.302926,"eighty":-0.097873,"marketCap":3595392},{"date":"2025-08-22","current":-0.349348,"twenty":-0.740118,"median":-0.303824,"eighty":-0.098183,"marketCap":3496273},{"date":"2025-08-29","current":-0.349348,"twenty":-0.737004,"median":-0.30806,"eighty":-0.098547,"marketCap":3496273},{"date":"2025-09-05","current":-0.376994,"twenty":-0.732571,"median":-0.309674,"eighty":-0.098601,"marketCap":3772957},{"date":"2025-09-12","current":-0.515225,"twenty":-0.725652,"median":-0.310597,"eighty":-0.09883,"marketCap":5156375},{"date":"2025-09-19","current":-0.485066,"twenty":-0.721003,"median":-0.310628,"eighty":-0.098953,"marketCap":4854538},{"date":"2025-09-26","current":-0.485066,"twenty":-0.714988,"median":-0.313195,"eighty":-0.099431,"marketCap":4854538},{"date":"2025-10-03","current":-0.495119,"twenty":-0.709175,"median":-0.313195,"eighty":-0.100278,"marketCap":4955150},{"date":"2025-10-10","current":-0.495119,"twenty":-0.70593,"median":-0.319536,"eighty":-0.100317,"marketCap":4955150},{"date":"2025-10-17","current":-0.490092,"twenty":-0.705684,"median":-0.323295,"eighty":-0.100364,"marketCap":4904844},{"date":"2025-10-24","current":-0.510199,"twenty":-0.704635,"median":-0.323682,"eighty":-0.100506,"marketCap":5106069},{"date":"2025-10-31","current":-0.402127,"twenty":-0.699489,"median":-0.325801,"eighty":-0.100531,"marketCap":4024488},{"date":"2025-11-07","current":-0.44234,"twenty":-0.690624,"median":-0.327169,"eighty":-0.100549,"marketCap":4426936},{"date":"2025-11-14","current":-0.424747,"twenty":-0.689408,"median":-0.328598,"eighty":-0.100733,"marketCap":4250865},{"date":"2025-11-21","current":-0.592993,"twenty":-0.687056,"median":-0.330989,"eighty":-0.101551,"marketCap":6668203},{"date":"2025-11-28","current":-0.581365,"twenty":-0.683272,"median":-0.333227,"eighty":-0.101876,"marketCap":6537454},{"date":"2025-12-05","current":-0.622061,"twenty":-0.68111,"median":-0.335826,"eighty":-0.102095,"marketCap":6995075},{"date":"2025-12-12","current":-0.153161,"twenty":-0.68111,"median":-0.33594,"eighty":-0.102277,"marketCap":1722292},{"date":"2025-12-19","current":-0.107465,"twenty":-0.680894,"median":-0.333373,"eighty":-0.102421,"marketCap":1208448},{"date":"2025-12-26","current":-0.09389,"twenty":-0.668096,"median":-0.333227,"eighty":-0.101795,"marketCap":1055798},{"date":"2026-01-02","current":-0.222132,"twenty":-0.664765,"median":-0.330813,"eighty":-0.102007,"marketCap":2497877},{"date":"2026-01-09","current":-0.255614,"twenty":-0.639107,"median":-0.328453,"eighty":-0.102204,"marketCap":2874381},{"date":"2026-01-16","current":-0.298412,"twenty":-0.613341,"median":-0.326031,"eighty":-0.102363,"marketCap":3355642},{"date":"2026-01-23","current":-0.243141,"twenty":-0.60444,"median":-0.325801,"eighty":-0.102491,"marketCap":2734124},{"date":"2026-01-30","current":-0.158339,"twenty":-0.599408,"median":-0.323682,"eighty":-0.102846,"marketCap":1780519},{"date":"2026-02-06","current":-0.264688,"twenty":-0.598806,"median":-0.323464,"eighty":-0.103421,"marketCap":3164613},{"date":"2026-02-13","current":-0.27194,"twenty":-0.597644,"median":-0.322042,"eighty":-0.103826,"marketCap":3251315},{"date":"2026-02-20","current":-0.308199,"twenty":-0.595644,"median":-0.319933,"eighty":-0.104126,"marketCap":3684823},{"date":"2026-02-27","current":-0.311825,"twenty":-0.59462,"median":-0.314478,"eighty":-0.10477,"marketCap":3728174},{"date":"2026-03-03","current":-0.30699,"twenty":-0.59462,"median":-0.314242,"eighty":-0.104916,"marketCap":3670373}],"updateTime":1772649617314},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616852325","title":"Gri Bio, Inc.盤中異動 早盤股價大跌5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616852325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616852325?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 22:30","pubTimestamp":1772461831,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时30分，Gri Bio, Inc.股票出现波动，股价大幅跳水5.49%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603022230319542a15c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603022230319542a15c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2610646634","title":"Gri Bio, Inc.盤中異動 急速下挫7.53%報2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610646634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610646634?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 22:39","pubTimestamp":1770647957,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时39分，Gri Bio, Inc.股票出现异动，股价快速下跌7.53%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223917a6e69302&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223917a6e69302&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"1182684414","title":"GRI BIO INC重申2025財年全年業績，強化資產負債表，並概述近期關鍵進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1182684414","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182684414?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 21:46","pubTimestamp":1770212773,"startTime":"0","endTime":"0","summary":"GRI BIO INC已正式重申其2025财年全年财务业绩，同时通过优化资本结构显著强化了公司资产负债表。此外，管理层还系统梳理并总结了近期在业务运营、研发进展及战略合作等方面的关键亮点，展现出公司在复杂市场环境中的稳健态势与成长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"1133623721","title":"GRI BIO INC公布引人注目的2a期新基因表達數據 顯示特發性肺纖維化關鍵驅動因子及肺修復指標改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1133623721","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133623721?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 21:47","pubTimestamp":1769608025,"startTime":"0","endTime":"0","summary":"GRI BIO INC最新发布的2a期临床试验基因表达数据取得突破性进展，该数据清晰表明在特发性肺纤维化治疗中，与纤维化进程和肺部组织修复相关的核心生物标志物呈现显著积极变化。研究结果揭示了实验疗法对疾病关键通路的影响，为后续临床开发提供了强有力的科学依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"1177458457","title":"GRI Bio Inc：GRI-0621持續展現卓越特性，兼具良好安全性與耐受性","url":"https://stock-news.laohu8.com/highlight/detail?id=1177458457","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177458457?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 21:05","pubTimestamp":1767877514,"startTime":"0","endTime":"0","summary":"GRI Bio Inc旗下在研药物GRI-0621的最新数据持续展现出引人瞩目的综合特性。该药物在临床前及早期临床研究中，不仅表现出良好的安全性特征，其耐受性结果也同样令人鼓舞。这种将优异安全性与可接受耐受性相结合的特点，为GRI-0621的后续开发奠定了坚实基础，凸显了其作为潜在疗法的独特优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"1113953690","title":"GRI Bio公布IPF二期a期研究新增積極數據，強化GRI-0621臨床概念驗證","url":"https://stock-news.laohu8.com/highlight/detail?id=1113953690","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113953690?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 21:05","pubTimestamp":1767877510,"startTime":"0","endTime":"0","summary":"GRI Bio近日宣布，其针对特发性肺纤维化（IPF）开展的二期a期临床研究获得额外积极数据。这些新发现进一步强化了候选药物GRI-0621的临床概念验证，为后续开发提供有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2595754405","title":"Gri Bio, Inc.盤中異動 早盤股價大跌5.40%報0.261美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595754405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595754405?lang=zh_tw&edition=fundamental","pubTime":"2025-12-29 22:59","pubTimestamp":1767020363,"startTime":"0","endTime":"0","summary":"北京时间2025年12月29日22时59分，Gri Bio, Inc.股票出现异动，股价急速下挫5.40%。截至发稿，该股报0.261美元/股，成交量95.7656万股，换手率16.31%，振幅9.75%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229225924a6dd918f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229225924a6dd918f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2591988652","title":"中國保險行業協會編撰出版《<保險機構環境、社會和治理信息披露指南>釋義及案例》","url":"https://stock-news.laohu8.com/highlight/detail?id=2591988652","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591988652?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 17:51","pubTimestamp":1765878660,"startTime":"0","endTime":"0","summary":"　　为深入贯彻党中央、国务院关于推动绿色发展、做好金融五篇大文章的决策部署，积极宣导环境、社会和治理理念，中国保险行业协会印发了《保险机构环境、社会和治理信息披露指南》。为加强《指南》的广泛应用，指导保险机构提升ESG信息披露实践，中国保险行业协会组织编撰了《<保险机构环境、社会和治理信息披露指南>释义及案例》。近日，《释义及案例》已正式出版发行。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/insurance/bxdt/2025-12-16/doc-inhaywrc3112313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GRI","ESG","BK4007","BK4139"],"gpt_icon":0},{"id":"1193690720","title":"GRI Bio Inc：第二階段2a研究達到了次要終點，並顯示膠原蛋白代謝標誌物的改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1193690720","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193690720?lang=zh_tw&edition=fundamental","pubTime":"2025-12-11 05:28","pubTimestamp":1765402089,"startTime":"0","endTime":"0","summary":"GRI Bio Inc：第二阶段2a研究达到了次要终点，并显示胶原蛋白代谢标志物的改善","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2590553514","title":"BUZZ-實驗性肺部藥物在中期試驗中表現良好，GRI 生物公司業績大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2590553514","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590553514?lang=zh_tw&edition=fundamental","pubTime":"2025-12-11 05:26","pubTimestamp":1765401994,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL4T3XG1M9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"1172310436","title":"GRI Bio公布特發性肺纖維化（「IPF」）II期2a研究的積極頂線數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1172310436","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172310436?lang=zh_tw&edition=fundamental","pubTime":"2025-12-11 05:06","pubTimestamp":1765400771,"startTime":"0","endTime":"0","summary":"GRI Bio公布特发性肺纤维化（“IPF”）II期2a研究的积极顶线数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"1197256579","title":"GRI Bio Inc - 試驗達到主要終點及某些次要終點；GRI-0621 耐受性良好 - SEC 備案","url":"https://stock-news.laohu8.com/highlight/detail?id=1197256579","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197256579?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 21:14","pubTimestamp":1765199651,"startTime":"0","endTime":"0","summary":"GRI Bio Inc - 试验达到主要终点及某些次要终点；GRI-0621 耐受性良好 - SEC 备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"1109567142","title":"GRI Bio Inc - 接收特發性肺纖維化2a期臨床試驗的初步數據 - SEC備案","url":"https://stock-news.laohu8.com/highlight/detail?id=1109567142","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109567142?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 21:13","pubTimestamp":1765199624,"startTime":"0","endTime":"0","summary":"GRI Bio Inc - 接收特发性肺纤维化2a期临床试验的初步数据 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2589812824","title":"我們找到了離「商業向善」最近的55家公司丨2025「可持續品牌典範」排行榜公示","url":"https://stock-news.laohu8.com/highlight/detail?id=2589812824","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589812824?lang=zh_tw&edition=fundamental","pubTime":"2025-12-06 21:31","pubTimestamp":1765027860,"startTime":"0","endTime":"0","summary":"历经两个月的公开征集与专业评审后，2025“可持续品牌典范”榜单已于近日正式揭晓。需要指出的是，本次评选中也有部分在ESG领域内享有声誉的企业未能上榜。虎嗅ESG承诺将持续倾听各界声音，认真总结经验，在明年的评选机制、流程设计与考察维度上进一步优化，努力呈现一份更公正、更全面、更具参考价值的可持续品牌典范榜。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656136076&idx=3&sn=d6e34518a3d5cf8bbe5baa9a07aad973&chksm=673dfea6eb2e31c39b6e90501da70e33ccad93d9130b0d6cfdbf3bb32bbbae849ecb0abd6bff&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"2584973669","title":"我國綠色貿易領域首個專項政策文件出爐 綠色貿易邁向系統推進新階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2584973669","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584973669?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 13:54","pubTimestamp":1763531640,"startTime":"0","endTime":"0","summary":"作为平衡环境可持续和经济增长的关键环节，全球对于绿色贸易的关注度持续升温。　　多位业内专家对新浪财经表示，这一专项政策的出台，恰逢全球绿色转型加速、绿色贸易规则加速重构、中国“双碳”进入攻坚的关键期，为企业破解标准壁垒、提升国际竞争力提供了明确指引。标志着我国绿色贸易从政策倡导迈向系统推进的新阶段，尤其在产业链绿色协同与碳足迹核算方面的布局，意义深远。　　当前绿色贸易领域的机遇与挑战并存。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/esg/elecmagazine/2025-11-19/doc-infxxfwh1934151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","BK4139","SINA","GRI"],"gpt_icon":0},{"id":"2584624479","title":"呂建中：企業應從三大方向把握綠色貿易新政機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2584624479","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584624479?lang=zh_tw&edition=fundamental","pubTime":"2025-11-17 22:49","pubTimestamp":1763390940,"startTime":"0","endTime":"0","summary":"新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。　　近日，商务部印发《关于拓展绿色贸易的实施意见》，首次以专项政策形式系统推动绿色贸易发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/esg/cg/2025-11-17/doc-infxtqvy3461927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SINA","BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2583631652","title":"我國綠色貿易領域首個專項政策文件出爐 綠色貿易邁向系統推進新階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2583631652","media":"新浪财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583631652?lang=zh_tw&edition=fundamental","pubTime":"2025-11-15 12:34","pubTimestamp":1763181240,"startTime":"0","endTime":"0","summary":"作为平衡环境可持续和经济增长的关键环节，全球对于绿色贸易的关注度持续升温。　　多位业内专家对新浪财经表示，这一专项政策的出台，恰逢全球绿色转型加速、绿色贸易规则加速重构、中国“双碳”进入攻坚的关键期，为企业破解标准壁垒、提升国际竞争力提供了明确指引。标志着我国绿色贸易从政策倡导迈向系统推进的新阶段，尤其在产业链绿色协同与碳足迹核算方面的布局，意义深远。　　当前绿色贸易领域的机遇与挑战并存。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/esg/ep/2025-11-15/doc-infxnfmx0657437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GRI","BK4007","SINA","BK4139"],"gpt_icon":0},{"id":"2582392464","title":"Gri Bio, Inc.盤中異動 下午盤快速拉升6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582392464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582392464?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 02:01","pubTimestamp":1762884063,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日02时01分，Gri Bio, Inc.股票出现异动，股价急速上涨6.32%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.55%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111202010394fe1f44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111202010394fe1f44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2576323050","title":"全球報告倡議組織（GRI）前董事呂建中：ESG標準建設需把握「三組平衡」，推動上海可持續發展與國際接軌","url":"https://stock-news.laohu8.com/highlight/detail?id=2576323050","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576323050?lang=zh_tw&edition=fundamental","pubTime":"2025-10-17 19:36","pubTimestamp":1760700960,"startTime":"0","endTime":"0","summary":"　　2025可持续全球领导者大会于10月16日-18日在上海市黄浦区世博园区召开。　　全球报告倡议组织前董事吕建中出席会议并参与主题对话。在当前全球可持续发展议程深度演进、国际标准格局加速重塑的背景下，吕建中的“平衡”理念，不仅关乎标准本身的有效性，更关乎中国在全球绿色治理中话语权的提升，对推动高质量发展具有重要的现实指导意义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-10-17/doc-infufcyf1434851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","GRI","159717","BK4007","ESG"],"gpt_icon":0},{"id":"2575732577","title":"Gri Bio, Inc.盤中異動 早盤大幅拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575732577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575732577?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 21:37","pubTimestamp":1760535425,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日21时37分，Gri Bio, Inc.股票出现异动，股价快速拉升5.24%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。GRI Bio的项目GRI-0621是一种小分子RAR-beta和gamma双重激动剂，能抑制人类NKT I细胞的活性，使免疫系统恢复到稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015213705a6bae766&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015213705a6bae766&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}]}}